Advocacy Groups Suspend Applications for Suicide Capsule Amid Ongoing Swiss Investigation

Advocacy groups have halted applications for a controversial suicide capsule, pending a criminal investigation in Switzerland. Over 370 applications were received last month. The Last Resort's president, Florian Willet, is in pretrial detention. Exit International, an Australian-founded affiliate, confirmed this. Swiss police arrested Willet and others after a 64-year-old American woman used the device on September 23 in Schaffhausen, near Germany.

Switzerland's laws on assisted suicide are among the world's most lenient. However, the Sarco's first use has sparked legislative debate. The country's laws allow assisted suicide if the person acts independently and helpers have no selfish motives. The advocacy groups stated that 371 people had applied to use the Sarco by September 23, but applications were paused following its initial use.

Legal and Ethical Concerns

Exit International, led by Dr Philip Nitschke from the Netherlands, developed the Sarco capsule at a cost exceeding USD 1 million. This 3D-printed device allows users to press a button, releasing nitrogen gas into a sealed chamber. The process leads to sleep and death by suffocation within minutes. Exit International claims Willet was alone during the woman's death, describing it as peaceful and dignified, though these claims remain unverified.

On the same day as the incident, Swiss Health Minister Elisabeth Baume-Schneider informed parliament that using the Sarco is illegal. The woman reportedly had severe immune compromise. Exit International's lawyers argue that using the device is legal in Switzerland. They stated that Ms Baume-Schneider's comments coincided with the event unintentionally.

Investigation and Reactions

Authorities released others initially detained after questioning. The incident has intensified discussions about assisted suicide laws in Switzerland. Advocacy groups are awaiting the investigation's outcome before proceeding with further applications for the Sarco device.

The Sarco capsule's introduction has raised ethical questions about assisted suicide methods. While some see it as a dignified option for those suffering, others question its implications and legality under current Swiss law.

The case highlights ongoing debates over assisted suicide practices worldwide. As investigations continue, advocacy groups and lawmakers will likely reassess regulations surrounding such devices.